|Bid||44.85 x 0|
|Ask||45.54 x 0|
|Day's range||44.52 - 45.50|
|52-week range||43.97 - 45.50|
|Beta (5Y monthly)||1.33|
|PE ratio (TTM)||302.08|
|Forward dividend & yield||1.65 (3.68%)|
|1y target est||N/A|
German drugs and pesticides maker Bayer has no plans to split its three main businesses into separately traded companies, Chief Executive Werner Baumann said, amid a flurry of conglomerates moving to break themselves up. "We are going to continue the course, which is developing our company along the three pillars that we have - pharmaceuticals, crop science and consumer health," Baumann told Bloomberg in an interview published on Thursday. The comments come after conglomerates such as Johnson & Johnson, Toshiba and General Electric announced plans this month to split up, aiming to simplify their structures and increase focus.
(Bloomberg) -- Bayer AG and Microsoft Corp. are collaborating on new internet-based products aimed at helping farmers and industries tied to agriculture become more efficient and sustainable.Most Read from BloombergStartup Fever Is Gripping the World’s Last Big Untapped NationWhat Designers of Video Game Cities Understand About Real CitiesElizabeth Holmes Faces Last-Ditch Chance to Testify at TrialChronically Underfunded HBCUs Eye Scholarships in Biden BillBayer is partnering with the U.S. softw
AstraZeneca (AZN) and Bayer (BAYRY) announce Q3 results. Pfizer's (PFE) COVID-19 pill reduces hospitalizations and deaths substantially.